2-(2-Fluorophenyl)-N-hydroxy-2-(4-(5-(trifluoromethyl)pyrimidin-2-yl)phenyl)acetamide

Catalog No. :
ACKHLQ934
CAS No. :
1629729-98-1
Molecular Formula :
C19H13F4N3O2
Molecular Weight :
391.32

IUPAC Name:2-(2-fluorophenyl)-N-hydroxy-2-(4-(5-(trifluoromethyl)pyrimidin-2-yl)phenyl)acetamide

2-(2-Fluorophenyl)-N-hydroxy-2-(4-(5-(trifluoromethyl)pyrimidin-2-yl)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg98%$60.00Login to see priceInquiryInquiry
5mg98%$153.00Login to see priceIn stockInquiry
10mg98%$280.00Login to see priceIn stockInquiry
25mg98%$497.00Login to see priceIn stockInquiry
50mg98%$718.00Login to see priceIn stockInquiry
100mg98%$998.00Login to see priceIn stockInquiry
250mg98%$1348.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Fluorophenyl)-N-hydroxy-2-(4-(5-(trifluoromethyl)pyrimidin-2-yl)phenyl)acetamide
IUPAC Name2-(2-fluorophenyl)-N-hydroxy-2-(4-(5-(trifluoromethyl)pyrimidin-2-yl)phenyl)acetamide
Molecular FormulaC19H13F4N3O2
Molecular Weight391.32
SMILESFC1=C(C=CC=C1)C(C(NO)=O)C2=CC=C(C3=NC=C(C(F)(F)F)C=N3)C=C2
InChI KeyLMGDHGQJJLEAPQ-UHFFFAOYSA-N
Synonym2-(2-Fluorophenyl)-N-hydroxy-2-(4-(5-(trifluoromethyl)pyrimidin-2-yl)phenyl)acetamide | CHDI-390576
CAS No.1629729-98-1
PubChem CID81689842

Synthetic Route by SureRoute

1. ACKHLQ934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKHLQ934 route product structure diagram
    ACKHLQ9341629729-98-1 In Stock
Inquiry

2. ACKHLQ934 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKHLQ934 route product structure diagram
    ACKHLQ9341629729-98-1 In Stock
Inquiry

Comments (0)